Jitendra Wadhane is SVP, Chief Accounting Officer of Pyxis Oncology, Inc.. Currently has a direct ownership of 398,421 shares of PYXS, which is worth approximately $1.62 Million. The most recent transaction as insider was on Mar 26, 2024, when has been sold 131,484 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 398K
0% 3M change
49.26% 12M change
Total Value Held $1.62 Million

Jitendra Wadhane Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2024
BUY
Grant, award, or other acquisition
-
131,484 Added 24.81%
398,421 Common Stock
Nov 15 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 13.03%
266,937 Common Stock
Sep 27 2023
BUY
Open market or private purchase
$4,675 $1.87 p/Share
2,500 Added 1.09%
226,937 Common Stock
Sep 25 2023
BUY
Open market or private purchase
$8,850 $1.77 p/Share
5,000 Added 2.18%
224,437 Common Stock
Sep 22 2023
BUY
Open market or private purchase
$4,350 $1.74 p/Share
2,500 Added 1.13%
219,437 Common Stock
Sep 07 2023
BUY
Grant, award, or other acquisition
-
93,896 Added 30.7%
211,937 Common Stock
Mar 24 2023
BUY
Grant, award, or other acquisition
-
74,393 Added 45.63%
88,648 Common Stock
JW

Jitendra Wadhane

SVP, Chief Accounting Officer
Cambridge, MA

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Track Activities on PYXS